A new open-label trial published in June 2026 offers some of the most encouraging data yet on psilocybin-assisted therapy veterans living with treatment-resistant depression. According to the study, a single oral dose of 25 milligrams of psilocybin was associated with a 59 percent reduction in anxiety scores at three weeks, and those improvements in anxiety, […]